CStone Pharmaceuticals
Yu-Cheng Su has a strong background in research and development, particularly in the fields of quantitative systems pharmacology, data analysis, and physics. With experience in mentoring students at Udacity and the University of Waterloo, as well as leading teams in various projects at Delta Electronics and developing analytical tools at Falcota Technology, Yu-Cheng Su brings a wealth of expertise to the table. Currently working as a Senior Scientist at CStone Pharmaceuticals, Yu-Cheng Su continues to contribute to the scientific community with innovative solutions.
This person is not in the org chart
This person is not in any offices
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.